New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia

New approach for developing cancer vaccines could make immunotherapies more effective in acute myeloid leukemia retrieved 3 May 2024 from https://medicalxpress.com/news/2024-05-approach-cancer-vaccines-immunotherapies-effective.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.6 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based testsA novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukemia (AML), one of the most common types of blood cancers. A new study by WEHI researchers has revealed the combination of two existing drugs eradicated AML cancer cells in lab-based tests.
Source: medical_xpress - 🏆 101. / 51 Read more »

Targeting RAS proteins may prevent relapse in acute myeloid leukemiaRelapses in a common form of leukemia may be preventable following new research that has identified how the cancer develops resistance to first line treatments.
Source: medical_xpress - 🏆 101. / 51 Read more »

ACC: Ticagrelor monotherapy cuts bleeding risk in acute coronary syndromeTreatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and remained event-free for one month on dual antiplatelet therapy, according to a study published online April 7 in The Lancet to...
Source: medical_xpress - 🏆 101. / 51 Read more »